Dexcom Ventures

Dexcom Ventures operates as the corporate venture capital arm of Dexcom, investing in biosensing and data-driven healthcare innovation. The firm identifies and supports transformative technology platforms adjacent to or related to Dexcom’s core business. This approach cultivates advancements in medical technology, expanding into chronic health conditions through financial backing and partnerships.

Established in 2021, Dexcom Ventures was co-founded by Jason Halac, serving as Managing Director. The firm leverages expertise and legacy of its parent company, Dexcom. This initiative stemmed from the insight that strategic investments could both supplement Dexcom’s growth and accelerate novel solutions across the healthcare landscape.

Dexcom Ventures targets companies developing products that enhance global access to timely health data, aiming for improved health outcomes. Its vision focuses on driving the next wave of health innovations by fostering technologies providing personalized and actionable medical insights. The firm’s objective is to facilitate better healthcare for populations, addressing a wider array of health challenges.